Table 1 Comparison of clinical background factors among ruptured patients, unruptured patients, and healthy controls.

From: Association of anti SITH 1 antibody titer with mental stress and intracranial aneurysms

 

R group (n=24)

U group (n=26)

Control (n=23)

p value

Age, years

57.5 [48.8, 70.5]

55.0 [47.3, 58.8]

60.0 [55.0, 66.5]

0.086

Sex, female

15 (62.5)

14 (53.8)

8 (34.8)

0.15

Body mass index, kg/m2

21.5 [20.2, 23.1]

21.7 [20.4, 23.4]

23.1 [21.0, 24.4]

0.24

Smoking

   

0.16

Current

9 (40.9)

5 (19.2)

2 (9.1)

 

Past

4 (18.2)

7 (26.9)

5 (22.7)

 

Never

9 (40.9)

14 (53.8)

15 (68.2)

 

Drinking

8 (36.4)

9 (34.6)

6 (26.1)

0.77

Pre-existing diseases

    

Hypertension

10 (41.7)

6 (23.1)

6 (26.1)

0.36

Diabetes mellitus

0 (0)

1 (3.8)

3 (13.0)

0.11

Dyslipidemia

2 (8.3)

8 (30.8)

7 (30.4)

0.092

Congestive heart disease

0 (0)

0 (0)

0 (0)

NA

Chronic renal failure

1 (4.2)

0 (0)

0 (0)

0.64

Medication

    

NSAID

1 (4.3)

0 (0)

0 (0)

0.65

Statin

0 (0)

7 (26.9)

2 (8.7)

0.012*

Steroid

1 (4.3)

0 (0)

0 (0)

0.65

Anticoagulant

1 (4.3)

0 (0)

1 (4.3)

0.53

Antiplatelet

0 (0)

2 (7.7)

0 (0)

0.33

  1. NSAID, non-steroidal anti-inflammatory drugs. R group, patients with ruptured intracranial aneurism. U group, patients with unruptured intracranial aneurysm. *p < 0.05. Unless otherwise indicated, values represent the number of aneurysms (%) or median and interquartile range. Not all percentages total 100% due to rounding.